Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 801–900 of 1,000
Li, X., Zhu, M., Zang, M., Cao, D., Xie, Z., Liang, H., Bian, Z., Zhao, T., Hu, Z., & Xu, E. Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04254-w · Cited by 8
“While the roles of transcriptional regulation of cell cycle machinery via localized growth pathways in cell proliferation and organ size control are well-established [61, 62], it is less clear to what extent posttranscriptional regulation plays in cell cycle progression and organ size control.”
BackgroundLi, W., Long, X., Li, F., Cao, Y., Liu, J., Fu, S., Guo, W., & Hu, G. (2022) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13756 · Cited by 8
Zhao, K., Zhang, H., Lin, J., Xu, S., Liu, J., Qian, X., Yong-bing, G., Ren, G., Lu, X., Chen, B., et al. (2024) · Academic Radiology · doi:10.1016/j.acra.2024.03.031 · Cited by 8
“During early G1 phase, CCND1 functions as either a promoter of cell cycle progression from G1 to S phase (8) or as a growth factor sensor.”
Quiescence does not affect p53 and stress response by irradiation in human lung fibroblasts
Dai, J., Itahana, K., & Baskar, R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.076 · Cited by 8
Bellone, M., Svensson, A. M., Zaslav, A., Spitzer, S. G., Golightly, M. G., Celiker, M., Hu, Y., Ma, Y., & Ahmed, T. (2012) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-1-7 · Cited by 8
“Decreased expression of this protein results in stabilization of cyclinD-CDK4/6 complexes and facilitates cell cycle progression [32], which was shown to be sufficient for the development of T-PLL in mouse models [31].”
BackgroundSchizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1
Ito, H., Morishita, R., & Nagata, K. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.016 · Cited by 8
An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas
Schnier, J. B., Nishi, K., Harley, W. R., & Gorin, F. A. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9591-8 · Cited by 8
“Cyclin D1 regulates the activity of the cell cycle dependent kinase CDK4/6, and cyclin D1 levels are regulated by its subcellular localization between the nucleus and cytoplasm during cell cycle progression [ 11 ].”
BackgroundCaron, D., Winstall, É., Inaguma, Y., Michaud, S., Lettre, F., Bourassa, S., Kelly, I., Poirier, G. G., Faure, R. L., & Tanguay, R. M. (2008) · Journal of Proteome Research · doi:10.1021/pr8002497 · Cited by 8
Lavi, O., Ginsberg, D., & Louzoun, Y. (2011) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2011.8.445 · Cited by 9
Ochiai, N., Nishizuka, M., Osada, S., & Imagawa, M. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00954 · Cited by 8
Skirrow, R. C., & Helbing, C. C. (2007) · Cell and Tissue Research · doi:10.1007/s00441-006-0362-6 · Cited by 8
“The periodic expression of cyclin activator proteins is presumed to govern cell proliferation by activating Cdks during each phase of the cell cycle (Sherr and Roberts 1999, 2004).”
BackgroundInfluentialTranscriptional regulation of fibrillin‐2 gene by E2F family members in chondrocyte differentiation
柳野, 卓., Yuasa, K., Nagahama, M., Matsuda, Y., & Tsuji, A. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22029 · Cited by 8
Roles of DNA polymerase epsilon and TopBP1 in DNA replication and damage response
Hillukkala, T. (2006) · Cited by 8
Cell cycle proteins: Linking the cell cycle to tumors
Zhong, J., LIU, J., TANG, X., ZHOU, W., Guang-ming, S., ZENG, Y., ZHANG, X., ZHOU, J., Cao, L., Zhang, Q., et al. (2025) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2025.058760 · Cited by 9
Anwer, K. E., El‐Dydamony, N. M., Saleh, A., Altwaijry, N., & Husseiny, E. M. (2025) · Drug Development Research · doi:10.1002/ddr.70139 · Cited by 7
“Activation of CDK ‐ 2 leads to the phosphorylation of essential substrates involved in DNA replication, which allows the cell to enter the S phase and initiates DNA synthesis (Sherr and Roberts 2004; Cheng 1999).”
Feng, Y., Tu, S., Hou, Y., Shao, Y., Chen, L., Mai, Z.-H., Wang, Y.-X., Wei, J.-M., Zhang, S., Ai, H., et al. (2024) · Toxicology · doi:10.1016/j.tox.2024.153917 · Cited by 7
Padilha, E. K. A., Silva, W. F. D. S., Lins, A. A., & da Silva‐Júnior, E. F. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266340766250124063854 · Cited by 7
Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration
Plessis‐Belair, J., Russo, T., Rießland, M., & Sher, R. B. (2025) · Aging Cell · doi:10.1111/acel.70091 · Cited by 7
Role of the common chain in cell cycle progression of human malignant cell lines
Vigliano, I., Palamaro, L., Bianchino, G., Fusco, A., Vitiello, L., Grieco, V., Romano, R., Salvatore, M., & Pignata, C. (2012) · International Immunology · doi:10.1093/intimm/dxr114 · Cited by 7
Neurogenesis in the Cerebellum
Chizhikov, V. V., & Millen, K. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397265-1.00067-8 · Cited by 7
Mathematical modelling of reversible transition between quiescence and proliferation
Pandey, N., & Vinod, P. K. U. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198420 · Cited by 8
Alaiz-Noya, M., Berti, F., & Dietrich, S. (2022) · Journal of Anatomy · doi:10.1111/joa.13629 · Cited by 7
Ji, H., Qiao, O., Zhang, Y., Wang, W., Han, X., Zhang, X., Liu, C., & Gao, W. (2023) · Phytotherapy Research · doi:10.1002/ptr.7924 · Cited by 7
“It can promote cells from G2 phase of interphase to division phase through a series of complex interactions (Sherr & Roberts, 2004). experimental results, it shows that MAG triggers the arrest of G2-M cell cycle, and p53 may also be a participant.”
Laver, T., Nozell, S. E., & Benveniste, E. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_42 · Cited by 8
“Cyclin D1 is a protein that binds to and activates CDK2, which regulates cell cycle progression from the G1 phase into the S phase, while cyclin E promotes DNA synthesis (Baudino et al., 2003; Roberts and Sherr, 2003; Sherr, 2000; Sherr and Roberts, 2004).”
BackgroundPhosphorylation Mediated Regulation of Cdc25 Activity, Localization and Stability
Frazer, C., & Young, P. G. (2012) · InTech eBooks · doi:10.5772/48315 · Cited by 9
“individually essential for cell division.[92] There is considerable redundancy.”
BackgroundMutation of the DEAD-box helicase belle downregulates the cyclin-dependent kinase inhibitor Dacapo
Ambrus, A., & Frolov, M. V. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10953 · Cited by 7
CDKN1C (p57KIP2)mRNA expression in human retinoblastomas
Madhavan, J., Kandalam, M., Khetan, V., George, R. J., Bremner, R., & Kumaramanickavel, G. (2010) · Ophthalmic Genetics · doi:10.3109/13816810.2010.490544 · Cited by 7
“Trends in Neuroscience, 2006; 29(10): 563–570.”
Huang, C., Hsieh, N., Pan, M., Li, C., Chou, Y., Chiou, Y., & Lee, M. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.11.006 · Cited by 7
Jia, Z., Chen, Y., Yan, Y., & Zhao, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1423 · Cited by 7
50 years of research on the phenomena and epigenetic mechanism of neurogenesis
Fujita, S. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.10.005 · Cited by 7
Gustafson, M. P., Xu, C., Grim, J. E., Clurman, B. E., & Knudsen, B. S. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0093-0 · Cited by 7
“CDK activity driving entry into S phase is controlled by the regulation of cyclins and CDK inhibitors throughout the cell cycle (Sherr and Roberts 2004).”
BackgroundYarmishyn, A. A., Child, E. S., Elphick, L. M., & Mann, D. J. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.016 · Cited by 7
Visualizing Dynamic E2F-Mediated Repression In Vivo
Agromayor, M., Wloga, E. H., Naglieri, B., Abrashkin, J., Verma, K., & Yamasaki, L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02101-05 · Cited by 9
“Finally, the dispensability of the G1 cyclins (D or E type) and G1 CDKs (Cdk4/6 or Cdk2) throughout most or all tissues during mouse development has challenged the field to propose alternative mechanisms for pRB-mediated growth control (42, 51).”
BackgroundUnexpected Outcomes of CDK4/6 Inhibition
Choi, Y. J., & Siciński, P. (2013) · Oncotarget · doi:10.18632/oncotarget.912 · Cited by 7
Nomura-Komoike, K., Nishino, R., & Fujieda, H. (2024) · Scientific Reports · doi:10.1038/s41598-023-50485-7 · Cited by 6
“We first monitored expression of cell cycle-related genes including cyclin D1 ( Ccnd1 ), the regulator of early G1 phase, cyclin E ( Ccne1 and Ccne2 ) regulating G1/S transition, and cyclin A2 ( Ccna2 ) promoting S phase progression 11 , by quantitative RT-PCR (qRT-PCR).”
MethodThe Proliferation of Chang Liver Cells After Simulated Microgravity Induction
Hoang, H. N. Q., Ho, C. N. Q., Dang, L. T. T., Phan, N. L.-C., Chung, Đ. C., Nguyen, H. T. M., Le, C. P. M., Sơn, H. N., & Long, L. T. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030164 · Cited by 6
Escape from Cellular Quiescence
Sotillo, E., & Graña, X. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1770-6_1 · Cited by 6
“The increase in cyclin E expression and the sequestration of CKIs by cyclin D/CDK4-6 complexes ensure accumulation of CKI-free cyclin E/CDK2 complexes that can be phosphorylated on the activating T-loop of CDK2 by the CDK-activating kinase (CAK) (Kato et al., 1994; Kaldis et al., 1998; Sherr and Roberts, 2004 ).”
BackgroundLin, P., Lee, H.-M., Huang, C., Tai, T.-S., Chen, J., Chen, C., & Su, Y. (2020) · Anticancer Research · doi:10.21873/anticanres.14647 · Cited by 6
Lukoseviciute, M., Holzhauser, S., Pappa, E., Mandal, T., Dalianis, T., & Kostopoulou, O. N. (2023) · Oncology Reports · doi:10.3892/or.2023.8603 · Cited by 6
IGFBP7 promotes endothelial cell repair in the recovery phase of acute lung injury
He, R., Feng, B., Zhang, Y., Li, Y., Wang, D., & Yu, L. (2024) · Clinical Science · doi:10.1042/cs20240179 · Cited by 8
“Previous studies have reported that genes such as Ki67 [20] /Egfr [21] /Sox17 [22] /Cyclins [23] are actively expressed in proliferating cells, indicating that the cells are in an active state of proliferation.”
Li, H., Yuan, Y., Ramirez, C., Xia, C., Zhang, C., Kud, J., Kuhl, J. C., Caplan, A., Dandurand, L., & Xiao, F. (2024) · The Plant Cell · doi:10.1093/plcell/koae264 · Cited by 6
Cheah, P., Looi, L., Mun, K.-S., Rahman, N. A., & Teoh, K. (2011) · PubMed · Cited by 6
Bageghni, S. A., Frentzou, G. A., Drinkhill, M. J., Mansfield, W. M., Coverley, D., & Ainscough, J. (2016) · Biology Open · doi:10.1242/bio.021550 · Cited by 6
“Inmammalian cells G1 progression is regulated by cyclin D/CDK4/6 and cyclin E/CDK2 (Sherr and Roberts, 2004), while S-phase entry is promoted by cyclin E/CDK2 and cyclin A/CDK2 (Coverley et al., 2002).”
BackgroundHung, K.-C., Lin, M., Hsu, S.-W., Lee, C.-C., Huang, R.-Y., Wu, T.-S., & Chen, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.017 · Cited by 6
Ding, Y., Gao, Z., Chen, B., Rakariyatham, K., Suo, H., Tong, H., & Xiao, H. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1497671 · Cited by 6
“Cyclins and cyclin-dependent kinases (CDKs) are crucial in the regulation of cell cycle checkpoints in eukaryotes (29,30).”
BackgroundSharma, S. S., Pledger, W. J., & Kondaiah, P. (2022) · Aging · doi:10.18632/aging.204372 · Cited by 7
Redundancy in response to DNA damage: The key to protection of genome integrity
Darżynkiewicz, Z. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17525 · Cited by 8
SP8 Transcriptional Regulation of Cyclin D1 During Mouse Early Corticogenesis
Borello, U., Berarducci, B., Delahaye, E., Price, D. J., & Dehay, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00119 · Cited by 6
“Cyclin D1 is a major cell-cycle regulator (Ekholm and Reed, 2000; Sherr and Roberts, 2004) and has been shown to be at the heart of a regulatory network controlling the balance between”
BackgroundInfluentialDivya, V., Pushpa, V. L., Sarithamol, S., & Manoj, K. B. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2018.04.001 · Cited by 8
Divya, V., Lalithabhai, P. V., & Bahuleyan, M. K. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13452 · Cited by 6
Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.
Poi, M. J., Knobloch, T. J., Sears, M. T., Uhrig, L. K., Warner, B. M., Weghorst, C. M., & Li, J. (2014) · PubMed · Cited by 6
Coming Full Circle: Cyclin-Dependent Kinases as Anti-cancer Drug Targets
Fisher, R. P. (2009) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-3471-7_1 · Cited by 7
“In the classical model, dependence on distinct CDKs at different points in the cell cycle appeared to be a defining feature of metazoan cell division (Sherr and Roberts, 2004), with the multiple catalytic subunits providing essential specialization of functions in much the same way that different types of cyclin confe…”
BackgroundModeling Cell Cycle Control and Cancer with pRB Tumor Suppressor
Yamasaki, L. (2006) · Springer eBooks · doi:10.1007/b136682 · Cited by 7
Okada, Y., Chikura, S., Kimoto, T., & Iijima, T. (2024) · Genes and Environment · doi:10.1186/s41021-024-00298-5 · Cited by 5
Palbociclib as an Antitumor Drug: A License to Kill
Łupicka‐Słowik, A., Cossu, F., & Sieńczyk, M. (2024) · Molecules · doi:10.3390/molecules29225334 · Cited by 6
“The second canonical mechanism behind G1 to S phase progression is based on the sequestration of CDK inhibitors p21 and p27 that are responsible for binding and preventing cyclin E–CDK2 activity (which also phosphorylates Rb, thus facilitating tumorigenesis) [3].”
Phytochemical analysis and anti-lung cancer effects in vitro and in vivo of Eomecon chionantha root
Niu, J., Ran, Y., Hu, Q., Yang, N., Yang, L., Zhao, H., Yang, B., Tang, D., & Tian, M. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119847 · Cited by 5
Xu, Z., Jiang, Z., Feng, K., Zhang, H., Shi, C., Dèng, F., Wáng, H., & Ning, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-63295-4 · Cited by 5
Zhu, X., Wu, J., Chen, X., Shi, D., Hui, P., Wang, H., Wu, Z., Wu, S., Bao, W., & Fan, H. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137137 · Cited by 7
Gkionis, I. G., Tzardi, M. N., Alegakis, A. K., Datseri, G., Moustou, E., Saridakis, G., Michelakis, D., Krüger‐Krasagakis, S., Krasagakis, K., & de Bree, E. (2025) · Anticancer Research · doi:10.21873/anticanres.17450 · Cited by 5
“These complexes facilitate the cellular transition beyond the G1/S restriction point via phosphorylation of the protein retinoblastoma (Rb), producing the functional inactivation of Rb, the release of E2F transcription factors and the initiation of DNA replication (16, 17).”
A dual role of p21 in liver regeneration and hepatocarcinogenesis
Liedtke, C., & Trautwein, C. (2008) · Hepatology · doi:10.1002/hep.22588 · Cited by 5
Tang, W., Yu, P., Wang, Y., Kang, M., Sun, B., Yin, J., & Gu, H. (2015) · Europe PMC (PubMed Central) · Cited by 5
Li, S., Jiang, H., Liu, Z.-B., Yu, W., Cai, X.-S., Liu, C., Xie, W., Quan, F., Gao, W., Kim, N., et al. (2022) · Veterinary Medicine and Science · doi:10.1002/vms3.1009 · Cited by 5
“In addition, inhibition of TBX2 may also be associated with D-type cyclins (D1, D2, and D3) and CDK4/6 and disrupt the essential processes for entry into G1 phase (Sherr & Roberts, 2004).”
BackgroundWang, L., Chen, Y., Chen, R., Mao, F., Sun, Z. S., & Liu, X. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102948 · Cited by 6
Breast Cancer Associated Conventional and Advanced Therapies
Gautam, K. A., Singh, N., Tyagi, P., Jha, G., & Raman, A. (2023) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/nquuw5hfzg · Cited by 5
Feng, B., Wang, X., Qiu, D., Sun, H., Deng, J., Tan, Y. C., Ji, K., Xu, S., Zhang, S., & Tang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094953 · Cited by 7
“Cell cycle-specific transcriptional control and protein degradation mechanisms further ensure the precise temporal regulation of these proteins [10].”
BackgroundTai, J., Rao, Y., Fang, J., Huang, Z., Yu, Z., CHEN, X., ZHOU, W., Xiao, X., LONG, T., Yang, H. K., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4189 · Cited by 5
“S phase of the cell cycle required activation of CDK4, and CDK4 activation is controlled, in part, by a complex formation with its catalytic partner, cyclin D1 (23).”
Renal Hyperplasia and Hypertrophy
Griffin, S., & Shankland, S. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50030-9 · Cited by 5
Cyclin D1: A Golden Gene in Cancer, Cardiotoxicity, and Cardioprotection
Haybar, H., Shahrouzian, M., Gatavizadeh, Z., Saki, N., Maniati, M., & Zayeri, Z. D. (2021) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.112413 · Cited by 8
“CCND1 gene is an allosteric activator of CDK4/6, which has an important role in cell cycle regulation, not only via phosphorylation of pRB, p107, and p130, which inhibit the transcriptional activity of E2F transcription factors in their hypophosphorylated forms and G1 phase proceeding to S phase of the cell cycle but…”
BackgroundInfluentialLi, J., Chang, H., Yi, Z., Zhang, C., Sun, Q., & Qian, W. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30885 · Cited by 5
“Then in the late G1 phase, CDK2‐Cyclin E complex was proposed to stimulate the phosphorylation of Rb proteins, which contributes to further activation of E2F‐mediated transcription and subsequent transition from G1 to S phase by licensing DNA origins of replication (Sherr & Roberts, 1999, 2004).”
BackgroundPKC and Control of the Cell Cycle
Black, J. D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_8 · Cited by 7
Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells
Seabra, L., & Warenius, H. M. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.03.014 · Cited by 5
Vergnaud, J., Seguin, A., Marsaud, V., Clay, D., Renoir, J., & Sola, B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23310 · Cited by 5
“accumulates in LP-1 cells treated with RU, inactivation of cyclin/ CDK complexes could result from the formation of ternary complexes, p27 inhibiting cyclin D3/CDK4/6 and cyclin A/E/ CDK2 activities.(22) As presented in Figures 4a and 4b, p27 was sequestered exclusively by cyclin D3/CDK6 complexes in LP-1 cells.”
BackgroundMethodLian, J. B., & Stein, G. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50008-2 · Cited by 9
Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells
Roy, S., Mehta, D., Paradkar, A., Chovatiya, G. L., & Waghmare, S. K. (2024) · Communications Biology · doi:10.1038/s42003-024-06047-2 · Cited by 4
“Further,Dab2-cKOHFSCsshowedanincreasedexpressionof NFATc1,whichpositivelyregulatesquiescencebyrepressingCDK4 33,34 .”
Zhao, J., Xu, J., Yang, T., Yu, X., Cheng, C., Zhang, T., Ren, Z., Li, N., Yang, F., & Li, G. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00729-z · Cited by 4
“Discussion CDK4, a key factor associated with cell cycle regulation, is currently being utilised as an important target for cancer treatment [8].”
BackgroundChang-you, L., Li, X., Fang, C., Li, C., Xu, Y., & Guo, Y. (2024) · Acta Cirúrgica Brasileira · doi:10.1590/acb394324 · Cited by 6
Ibrahim, O. F., Maklad, R. M., Abdu-Allah, H. H. M., Syam, Y. M., & Bakhite, E. A.-G. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00346f · Cited by 4
Artichoke as a melanoma growth inhibitor
Mathew, A., Deng, Z., Nelson, C. J., Mayberry, T. G., Bai, Q., Lequio, M., Fajardo, E., Xiao, H., Wakefield, M. R., & Fang, Y. (2023) · Medical Oncology · doi:10.1007/s12032-023-02077-8 · Cited by 4
D-Type Cyclins and Gene Transcription
Sante, G. D., Casimiro, M. C., Li, Z., Ertel, A., Tompa, P., & Pestell, R. G. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_3 · Cited by 4
Mammalian Development and Cancer: A Brief History of Mice Lacking D-Type Cyclins or CDK4/CDK6
Kalaszczyńska, I., & Ciemerych, M. A. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_2 · Cited by 4
CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females
Aierken, K., Dong, Z., Abulimiti, T., Zhang, Y., Abuduxikuer, G., Tuerxun, G., Abudurexiti, G., Maimaitiaishan, A., Mijiti, P., & Abulizi, G. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.626 · Cited by 4
Role of RUNX Family Members in G1 Restriction-Point Regulation.
Lee, J.-W., & Bae, S. (2020) · PubMed Central · doi:10.14348/molcells.2019.0319 · Cited by 5
“In other words, during the R-point decision, which requires substantial time for collection of extracellular signals and intracellular information, the Cyclin D–CDK4/6 complex must be formed, whereas the Cyclin E–CDK2 complex must not be formed.”
BackgroundInfluentialHuang, L., Zhang, Y., Fu, H., Gu, W., & Mao, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01272-4 · Cited by 4
“The reduced expression of CCND1, a key player in cell cycle regulation, especially during the transition from G1 to S phase [34, 35], might potentially disrupt the normal functioning of podocytes.”
BackgroundRegulation of Cell Cycle During Liver Regeneration
Nevzorova, Y. A., & Trautwein, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420128-6.00011-7 · Cited by 4
Deregulation of Cell Cycle Machinery in Pancreatic Cancer
Nacusi, L. P., & Sheaff, R. J. (2007) · Pancreatology · doi:10.1159/000107398 · Cited by 4
“The decision to divide is determined by integration of multiple signals from the environment (e.g. from other cells, nutrients, growth factors, hormones), combined with an internal assessment of readiness and ability to complete a proliferative cycle. Current models (derived largely from analysis of immortalized mamma…”
BackgroundGenetic mouse models to investigate cell cycle regulation
Li, W., Kotoshiba, S., & Kaldis, P. (2009) · Transgenic Research · doi:10.1007/s11248-009-9276-x · Cited by 4
“Recent studies have revealed that deletion of the individual Cdks (Cdk2, Cdk4, Cdk6), cyclins (cyclin D1/2/3, cyclin E1/2, cyclin A1, cyclin B2), and Cdk inhibitors (Cip/Kip and INK4 families) resulted in limited phenotypes in specific tissues that did not affect the viability of the mice [reviewed in (Ciemerych and S…”
BackgroundExpression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer
Gu, J., Zhang, X., Yang, Z., & Wang, N. (2019) · Cancer Management and Research · doi:10.2147/cmar.s224026 · Cited by 4
“This has been observed in various cancers, such as breast, lung, bladder, cervical, and parathyroid cancer and lymphoma.(17,18) Many studies have focused on the expression of cyclin D1 and its splice variants cyclin D1a and cyclin D1b, which arise from a single-nucleotide polymorphism in theCCND1 gene in cervical canc…”
BackgroundEstablishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells
COSTA, A. V., Bonner, M. Y., Rao, S., Gilbert, L. C., Sasaki, M., Elsey, J., MacKelfresh, J. B., & Arbiser, J. L. (2020) · Cancers · doi:10.3390/cancers12020395 · Cited by 5
The Role of Centrosomes in Multiple Myeloma
Yan, B., & Chng, W. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-035-9_15 · Cited by 4
Quelle, D. E., Nteeba, J., & Darbro, B. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30060-8 · Cited by 6
Nguyen, T., Ko, H.-J., Tsai, P.-Y., Cheng, T., Tran, T.-H., Doan, L. H., Hsiao, M., Chang, P. M., Liu, H., Hong, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1464647 · Cited by 3
“…increase phosphorylation of eIF2 α at serine 51 to enhance proteasomal degradation of Cyclin D1-a regulator of G1/S transition (Raven et al., 2008; Sherr and Roberts, 2004), or upregulate p21 mRNA – a G1 phase inhibitor by activated ATF4 independent of p53 regulation (Inoue et al., 2017), which…”
BackgroundCdk6’s functions are critically regulated by its unique C-terminus
Schirripa, A., Schöppe, H., Nebenfuehr, S., Zojer, M., Klampfl, T., Kugler, V., Schmalzbauer, B. S., Ceylan, H., Uras, I. Z., Scheiblecker, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111697 · Cited by 3
Luo, S., Gailus-Durner, V., McGivern, B., Li, Q., Kottmeier, J., Ho, M., Mor‐Shaked, H., Elpeleg, O. N., Aref‐Eshghi, E., Brodeur, A. C., et al. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01863-4 · Cited by 3
“Among these substrates, Ccnd1, along with its catalytic counterpart cyclin-dependent kinase 4 (Cdk4), plays a crucial role in regulating G 1 phase length and in fl uences the decision of neural stem cells to proliferate or differentiate [41 – 44].”
Zhang, Z., Wáng, C., Guo, Y., Zhao, Z., Yang, Z. H., Xie, S., Hu, X., Huang, X., Jiang, Y., Xiao, B., et al. (2025) · Cancer Science · doi:10.1111/cas.70141 · Cited by 3
Chen, X., Feng, H., Liu, M., Cai, J., Sarwar, R., Li, X., Zhang, M., Li, X., Lin, X., Guo, Z., et al. (2025) · Physiologia Plantarum · doi:10.1111/ppl.70485 · Cited by 3
Kung, M., Chu, T., Hsieh, S., Li, C., Li, W., Yeh, B., & Wu, W. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118675 · Cited by 3
Makran, M., García‐Llatas, G., & Cilla, A. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2624469 · Cited by 3
“In the early stages of the G 1 stage, various isoforms of cyclin D participate, which are associated with CDK4 and CDK6 to initiate the expression of genes involved in the transition of the cell cycle from the G1 phase to the S phase (Sherr and Roberts 2004).”
Zeng, C., Tao, W., Hu, B., Guo, M. Z., & Li, C. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739276 · Cited by 3
Post-GWAS Validation of Target Genes Associated with HbF and HbA2 Levels
Caria, C. A., Faà, V., Porcu, S., Marongiu, M. F., Poddie, D., Perseu, L., Meloni, A., Vaccargiu, S., & Ristaldi, M. S. (2024) · Cells · doi:10.3390/cells13141185 · Cited by 3
“…with cyclin-dependent kinases 4 (CDK4) and 6 (CDK6) causes the phosphorylation of Retinoblastoma protein (pRB) and its related proteins, which, in turn, release E2F transcription factor 2 (E2F2), a key transcription factor that drives the transition from the G1 to S phase of the cell cycle [29–31].”
BackgroundGuo, X., Yang, L., Wang, Y., Yuan, M., Zhang, W., He, X., & Wang, Q. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.11.006 · Cited by 3
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.